Daniel Tasse - Net Worth and Insider Trading
Daniel Tasse Net Worth
The estimated net worth of Daniel Tasse is at least $5,093 dollars as of 2024-12-26. Daniel Tasse is the CHIEF EXECUTIVE OFFICER of DBV Technologies SA and owns about 1,709 shares of DBV Technologies SA (DBVT) stock worth over $5,093. Details can be seen in Daniel Tasse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Tasse has not made any transactions after 2024-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Tasse
Daniel Tasse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Tasse owns 5 companies in total, including Regenxbio Inc (RGNX) , Bellerophon Therapeutics Inc (BLPH) , and Mallinckrodt PLC (MNKKQ) among others .
Click here to see the complete history of Daniel Tasse’s form 4 insider trades.
Insider Ownership Summary of Daniel Tasse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGNX | Regenxbio Inc | 2016-08-15 | director |
| BLPH | Bellerophon Therapeutics Inc | 2015-02-13 | director |
| MNKKQ | Mallinckrodt PLC | 2015-05-01 | Interim Pres-Hospital Business |
 | | 2024-03-08 | director & Chief Executive Officer |
| | 2015-05-01 | Interim Pres-Hospital Business |
Daniel Tasse Latest Holdings Summary
Daniel Tasse currently owns a total of 1 stock. Daniel Tasse owns 1,709 shares of DBV Technologies SA (DBVT) as of March 8, 2024, with a value of $5,093.
Latest Holdings of Daniel Tasse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DBVT | DBV Technologies SA | 2024-03-08 | 1,709 | 2.98 | 5,093 |
Holding Weightings of Daniel Tasse
Daniel Tasse Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Tasse has made a total of 1 transactions in DBV Technologies SA (DBVT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DBV Technologies SA is the acquisition of 1,709 shares on March 8, 2024, which cost Daniel Tasse around $14,188.
Insider Trading History of Daniel Tasse
- 1
Daniel Tasse Trading Performance
GuruFocus tracks the stock performance after each of Daniel Tasse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Tasse is -41.14%. GuruFocus also compares Daniel Tasse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Tasse within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Tasse's insider trading performs compared to the benchmark.
Performance of Daniel Tasse
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.24 | | | | | |
| Relative Return to S&P 500(%) | -11.78 | | | | | |
Daniel Tasse Ownership Network
Daniel Tasse Owned Company Details
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Daniel Tasse is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Daniel Tasse made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .
In summary, during the past 3 months, insiders sold 10,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
Daniel Tasse Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Tasse. You might contact Daniel Tasse via mailing address: C/o Ikaria, Inc., 6 State Route 173, Clinton Nj 08809.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
